Fig. 5From: Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysisForest plot of hazard ratios and 95% confidence intervals for overall survival by characteristics of patients. PF, platinum plus fluoropyrimidines; TPF, taxanes, platinum plus fluoropyrimidines; AJCC, American Joint Committee on Cancer; HR, hazard ratio; 95% CI, 95% confidence intervalBack to article page